[ad_1] MUMBAI, Indien, 7. Oktober 2024 /PRNewswire/ —  Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635) hat seinen dritten unabhängigen jährlichen Nachhaltigkeitsbericht für das Geschäftsjahr 2023/24 unter dem Motto „Building Resilience Today for a Sustainable […]

[ad_1] MUMBAI, India, Oct. 4, 2024 /PRNewswire/ — Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635) has released its third independent annual Sustainability Report for the financial year 2023-24, under the theme ‘Building Resilience Today […]